|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Venous endotelin- 1 (ET-1) and brain natriuretic peptide (BNP) plasma lev- els during 6-month bosentan treatment for pulmonary arterial hypertension显示文摘 | Vizza CD Letizia C Petramala L | 2008 | Regul Pept2008，151，13： | 1 |
| 2 | Right and left ventricular dysfunction in patients with severe pulmonary disease显示文摘 | Vizza CD Lynch JP Ochoa LL | 1998 | Chest1998，113，3： | 1 |
| 3 | Long term treatment of pulmonary artery hypertension with beraprost,an oral prostacyclin analogue显示文摘 | Vizza CD Sciomer S Morelli S | 2001 | Heart2001，86，： | 1 |
| 4 | Plasma adrenomedullin and endothelin-1 concentration during lowdose dobutamine infusion: relation ship between pulmonary uptake and pulmonary vascular pressure/flow characteristics显示文摘 | Vizza CD Letizia C Badagliacca R | 2006 | Regul Pept2006，136，13： | 1 |
| 5 | Safety and efficacy evalu ation of amhrisentan in pulmonary hypertension 显示文摘 | Vizza CD Fedele F Pezzuto B | 2012 | Drug Safety Evaluation2012，11，6： | 1 |
| 6 | Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease(Eisenmenger physiology):safety,tolerability,clinical,and haemodynamic effect显示文摘 | D'Alto M Vizza CD Romeo E | 2007 | Heart2007，93，5： | 1 |
| 7 | Long term treatment of pulmonary arterial hypertension with beraprost,an oral prostacyclin analogue显示文摘 | Vizza CD Sciomer S Morelli S | 2001 | Heart2001，86，： | 1 |
| 8 | Mid -term efficacy of beraprost,an oral prostacyclin analog,in the treatment of distal CTEPH:a case control study显示文摘 | Vizza CD Badagliacca R Sciomer S | 2006 | Cardiology2006，106，： | 1 |
| 9 | Chronic thromboembolic pulmonary hypertension显示文摘 | Zonzin P Vizza CD Favretto G | 2003 | Ital Heart J Suppl2003，4，10： | 1 |
| 10 | Long-term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect显示文摘 | D'ALTO M VIZZA CD ROMEO E | 2007 | Heart2007，93，5： | 1 |
| 11 | Venous endothelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension显示文摘 | Vizza CD Letizia C Petramala L | 2008 | Regul Pept2008，151，13： | 1 |
| 12 | Long term effects of bosentan treatment in aduh patients with pulmonary arterial hypertension relat- ed to congenital heart disease ( Eisenmenger physiology) : safety, tolerability, clinical, and haemodynamic effect 显示文摘 | D'Aho M Vizza CD Romeo E | 2007 | Heart2007，3，5： | 1 |
| 13 | Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension显示文摘 | Vizza CD Letizia C Petramala L | 2008 | Regul Pept2008，151，13： | 1 |
| 14 | Venous endotelin-1 (ETA) and brain natriuretic peptide ( BNP ) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension 显示文摘 | Vizza CD Eetizia C Petramala L | 2008 | Regul Pept2008，151，13： | 1 |
| 15 | Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study 显示文摘 | Vizza CD Badagliacca R Sciomer S | 2006 | Cardiology2006，106，3： | 1 |
| 16 | Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease ( Eisenmenger physiology ) : safety, talerability, clinical, and haemedynamic effect 显示文摘 | D'Aho M Vizza CD Romeo E | 2007 | Heart2007，93，： | 1 |
| 17 | Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease( Eisenmenger physiology) :Safety, tolerability, clinical, and haemodynamic effect 显示文摘 | D'Aho M Vizza CD Romeo E | 2007 | Heart2007，93，5： | 1 |
| 18 | Relationship between base- line ET-1 plasma levels and outcome in patients with idiopathic pulmo- nary hypertension treated with bosentan 显示文摘 | Vizza CD Letizia C Badagliacca R | 2013 | Int J Cardiol2013，167，1： | 1 |
| 19 | Relationship between baseline ET -1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan显示文摘 | Vizza CD Letizia C Badagliacca R | 2013 | Int J Cardiol2013，，： | 1 |
| 20 | Right and left ventricular dysfunction in patients with severe pulmonary disease显示文摘 | Vizza CD Lynch JP Ochoa LL | 1998 | Chest1998，113，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员